206 related articles for article (PubMed ID: 10854220)
21. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.
Günthard HF; Wong JK; Spina CA; Ignacio C; Kwok S; Christopherson C; Hwang J; Haubrich R; Havlir D; Richman DD
J Infect Dis; 2000 Feb; 181(2):522-31. PubMed ID: 10669335
[TBL] [Abstract][Full Text] [Related]
22. [AIDS: new developments. VI. HIV reservoirs during intensive antiretroviral treatment].
Notermans DW; Danner SA; de Wolf F; Lange JM
Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1909-12. PubMed ID: 9856176
[TBL] [Abstract][Full Text] [Related]
23. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals.
Ribas SG; Ondoa P; Schüpbach J; van der Groen G; Fransen K
J Virol Methods; 2003 Oct; 113(1):29-34. PubMed ID: 14500124
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 DNA and RNA kinetics in primary HIV infection.
Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
[TBL] [Abstract][Full Text] [Related]
25. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
26. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.
Schüpbach J; Tomasik Z; Knuchel M; Opravil M; Günthard HF; Nadal D; Böni J; ;
J Med Virol; 2006 Aug; 78(8):1003-10. PubMed ID: 16789014
[TBL] [Abstract][Full Text] [Related]
27. Viral load and progression.
PI Perspect; 1997 Mar; (No 21):6-7. PubMed ID: 11364214
[TBL] [Abstract][Full Text] [Related]
28. Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy.
Fischer M; Günthard HF; Opravil M; Joos B; Huber W; Bisset LR; Ott P; Böni J; Weber R; Cone RW
AIDS Res Hum Retroviruses; 2000 Aug; 16(12):1135-40. PubMed ID: 10954888
[TBL] [Abstract][Full Text] [Related]
29. Cystatin A and HIV-1 p24 antigen expression in tonsillar lymphoid follicles during HIV-1 infection and during highly active antiretroviral therapy.
Voltersvik P; Bostad L; Dyrhol-Riise AM; Eide GE; Røsok BI; Olofsson J; Asjö B
J Acquir Immune Defic Syndr; 2006 Mar; 41(3):277-84. PubMed ID: 16540928
[TBL] [Abstract][Full Text] [Related]
30. Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.
Cohen OJ; Pantaleo G; Lam GK; Fauci AS
Springer Semin Immunopathol; 1997; 18(3):305-22. PubMed ID: 9089951
[TBL] [Abstract][Full Text] [Related]
31. Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA.
Schüpbach J; Böni J; Flepp M; Tomasik Z; Joller H; Opravil M
J Med Virol; 2001 Oct; 65(2):225-32. PubMed ID: 11536227
[TBL] [Abstract][Full Text] [Related]
32. Detecting Sources of Immune Activation and Viral Rebound in HIV Infection.
Wietgrefe SW; Duan L; Anderson J; Marqués G; Sanders M; Cummins NW; Badley AD; Dobrowolski C; Karn J; Pagliuzza A; Chomont N; Sannier G; Dubé M; Kaufmann DE; Zuck P; Wu G; Howell BJ; Reilly C; Herschhorn A; Schacker TW; Haase AT
J Virol; 2022 Aug; 96(15):e0088522. PubMed ID: 35856674
[TBL] [Abstract][Full Text] [Related]
33. Use of virologic markers in clinical practice.
Saag MS
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 16 Suppl 1():S3-13. PubMed ID: 9389310
[TBL] [Abstract][Full Text] [Related]
34. Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients.
Knuchel MC; Speck RF; Schlaepfer E; Kuster H; Ott P; Günthard HF; Opravil M; Cone RW; Weber R
AIDS; 2000 Dec; 14(17):2661-9. PubMed ID: 11125884
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 upregulates intercellular adhesion molecule-1 gene expression in lymphoid tissue of patients with chronic HIV-1 infection.
Garrido M; Mozos A; Martínez A; García F; Serafín A; Morente V; Caballero M; Gil C; Fumero E; Miró JM; Climent N; Gatell JM; Alos L
J Acquir Immune Defic Syndr; 2007 Nov; 46(3):268-74. PubMed ID: 17786132
[TBL] [Abstract][Full Text] [Related]
36. HIV expression in surgical specimens.
Orenstein JM
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):947-55. PubMed ID: 18671477
[TBL] [Abstract][Full Text] [Related]
37. Lymphoid changes of the nasopharyngeal and palatine tonsils that are indicative of human immunodeficiency virus infection. A clinicopathologic study of 12 cases.
Wenig BM; Thompson LD; Frankel SS; Burke AP; Abbondanzo SL; Sesterhenn I; Heffner DK
Am J Surg Pathol; 1996 May; 20(5):572-87. PubMed ID: 8619422
[TBL] [Abstract][Full Text] [Related]
38. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy.
Popovic M; Tenner-Racz K; Pelser C; Stellbrink HJ; van Lunzen J; Lewis G; Kalyanaraman VS; Gallo RC; Racz P
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14807-12. PubMed ID: 16199516
[TBL] [Abstract][Full Text] [Related]
39. Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.
Marozsan AJ; Fraundorf E; Abraha A; Baird H; Moore D; Troyer R; Nankja I; Arts EJ
J Virol; 2004 Oct; 78(20):11130-41. PubMed ID: 15452233
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus type 1 dynamics in different lymphoid tissue compartments.
Lafeuillade A; Poggi C; Tamalet C; Profizi N
J Infect Dis; 1997 Sep; 176(3):804-6. PubMed ID: 9291339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
